Physician profile
Irwin Michael Mandel
NPI 1245248558
$2,865.37
in general payments reported to CMS, 2019-2025
8 companies · $476 in 2025
The $476 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $195 · 2021: $326 · 2022: $437 · 2023: $471 · 2024: $343 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,683.05 | 2019-2025 | Accolade, Mako, Blueprint Patient Specific Instrumentation |
| Vericel Corporation | $552.18 | 2019-2025 | Maci |
| Djo, LLC | $259.27 | 2019-2021 | |
| Smith+Nephew, INC. | $143.62 | 2021 | |
| Horizon Therapeutics Plc | $120.78 | 2019 | |
| Organogenesis INC. | $48.05 | 2024-2025 | Puraply Wound Matrix |
| Depuy Synthes Sales INC. | $35.17 | 2021 | |
| Mimedx Group, INC. | $23.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Mandel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.